A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 3, 2012, Pages 887-892

  Miles, Katherine ^a   Heaney, Jonathan ^a   Sibinska, Zaneta ^a   Salter, Donald ^a   Savill, John ^a   Gray, David ^b   Gray, Mohini ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL INTERACTION; DNA PROTEIN COMPLEX; ENCEPHALITIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOGNITION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD27; APOPTOSIS; B-LYMPHOCYTES; CELL COMMUNICATION; DEOXYRIBONUCLEASES; DNA; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INTERLEUKIN-10; MICE; MURAMIDASE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

MUS;

EID: 84856373688     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1109173109     Document Type: Article

References (66)

1. Fadok VA, et al. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 101:890-898. (Pubitemid 28096086)
2. Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: Clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965-975. (Pubitemid 37323217)
3. Savill J, Fadok V (2000) Corpse clearance defines the meaning of cell death. Nature 407:784-788.
4. Stuart LM, et al. (2002) Inhibitory effects of apoptotic cell ingestion upon endotox-indriven myeloid dendritic cell maturation. J Immunol 168:1627-1635. (Pubitemid 34135757)
5. Voll RE, et al. (1997) Immunosuppressive effects of apoptotic cells. Nature 390:350-351.
6. Notley CA, Brown MA, Wright GP, Ehrenstein MR (2011) Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J Immunol 186:4967-4972.
7. Chen Y, et al. (2009) Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 183:1346-1359.
8. Gray M, Miles K, Salter D, Gray D, Savill J (2007) Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA 104:14080-14085. (Pubitemid 350003338)
9. Ferry H, Jones M, Vaux DJ, Roberts IS, Cornall RJ (2003) The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J Exp Med 198:1415-1425. (Pubitemid 37392486)
10. Steele EJ, Cunningham AJ (1978) High proportion of Ig-producing cells making autoantibody in normal mice. Nature 274:483-484. (Pubitemid 8396810)
11. Souroujon M, White-Scharf ME, Andreschwartz J, Gefter ML, Schwartz RS (1988) Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice. J Immunol 140:4173-4179.
12. + memory B cells. Immunity 26: 205-213.
13. Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF (1997) Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 9:27-41. (Pubitemid 27062886)
14. Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317-1330. (Pubitemid 24091790)
15. Plotz PH (2003) The autoantibody repertoire: Searching for order. Nat Rev Immunol 3:73-78.
16. Cocca BA, Cline AM, Radic MZ (2002) Blebs and apoptotic bodies are B cell autoantigens. J Immunol 169:159-166. (Pubitemid 34686132)
17. Radic M, Marion T, Monestier M (2004) Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 172:6692-6700. (Pubitemid 38669105)
18. Lau CM, et al. (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 202:1171-1177. (Pubitemid 41586947)
19. Leadbetter EA, et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607. (Pubitemid 34406754)
20. Christensen SR, et al. (2005) Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 202:321-331. (Pubitemid 41043827)
21. Lartigue A, et al. (2006) Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. J Immunol 177:1349-1354. (Pubitemid 44036642)
22. Wu X, Peng SL (2006) Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 54:336-342. (Pubitemid 43122217)
23. Yu P, et al. (2006) Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. Int Immunol 18:1211-1219. (Pubitemid 44349296)
24. Christensen SR, et al. (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25:417-428. (Pubitemid 44354217)
25. Nickerson KM, et al. (2010) TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol 184:1840-1848.
26. Bouaziz JD, et al. (2010) IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 40:2686-2691.
27. Iwata Y, et al. (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117:530-541.
28. Illera VA, Perandones CE, Stunz LL, Mower DA, Jr., Ashman RF (1993) Apoptosis in splenic B lymphocytes: Regulation by protein kinase C and IL-4. J Immunol 151:2965-2973. (Pubitemid 23282609)
29. Cyster JG, Hartley SB, Goodnow CC (1994) Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371:389-395. (Pubitemid 24302553)
30. Goodnow CC, et al. (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676-682.
31. Phan TG, et al. (2003) B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med 197:845-860. (Pubitemid 36437862)
32. Barr TA, Brown S, Ryan G, Zhao J, Gray D (2007) TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol 37:3040-3053. (Pubitemid 350131284)
33. Vilaysane A, Muruve DA (2009) The innate immune response to DNA. Semin Immunol 21:208-214.
34. Yi AK, et al. (1998) CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 160:4755-4761.
35. Ehrenstein MR, Notley CA (2010) The importance of natural IgM: Scavenger, protector and regulator. Nat Rev Immunol 10:778-786.
36. Hayakawa K, et al. (1999) Positive selection of natural autoreactive B cells. Science 285:113-116. (Pubitemid 29307578)
37. Ferry H, Crockford TL, Leung JC, Cornall RJ (2006) Signals from a self-antigen induce positive selection in early B cell ontogeny but are tolerogenic in adults. J Immunol 176:7402-7411. (Pubitemid 43849042)
38. Barr TA, Brown S, Mastroeni P, Gray D (2010) TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica. J Immunol 185:2783-2789.
39. Crawford A, Macleod M, Schumacher T, Corlett L, Gray D (2006) Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol 176:3498-3506. (Pubitemid 43363997)
40. Yanaba K, et al. (2008) B-lymphocyte contributions to human autoimmune disease. Immunol Rev 223:284-299. (Pubitemid 351986191)
41. Blander JM, Medzhitov R (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440:808-812.
42. Baumgarth N (2011) The double life of a B-1 cell: Self-reactivity selects for protective effector functions. Nat Rev Immunol 11:34-46.
43. Qian Y, Wang H, Clarke SH (2004) Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J Immunol 172:625-635. (Pubitemid 38020521)
44. Wen ZK, et al. (2007) DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 46:1796-1803. (Pubitemid 350168294)
45. Krieg AM (2006) Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 5:471-484.
46. Barton GM, Kagan JC, Medzhitov R (2006) Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7:49-56. (Pubitemid 41823868)
47. Roberts TL, et al. (2010) B cells do not take up bacterial DNA: An essential role for antigen in exposure of DNA to toll-like receptor-9. Immunol Cell Biol 89:517-525.
48. Chaturvedi A, Dorward D, Pierce SK (2008) The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 28:799-809.
49. Busconi L, et al. (2007) Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9. J Immunol 179:7397-7405.
50. Wu HJ, et al. (2007) Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross-talk. J Exp Med 204:1911-1922.
51. Quintana FJ, Rotem A, Carmi P, Cohen IR (2000) Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: Modulation of spontaneous 60-kDa heat shock protein autoimmunity. J Immunol 165:6148-6155.
52. Rachmilewitz D, et al. (2002) Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122:1428-1441. (Pubitemid 34465184)
53. Gilkeson GS, et al. (1996) Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med 183:1389-1397. (Pubitemid 26134282)
54. Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6:823-835.
55. Yasuda K, et al. (2009) Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes. J Immunol 183:3109-3117.
56. Hemmi H, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745. (Pubitemid 32015992)
57. Leadbetter EA, Rifkin IR, Marshak-Rothstein A (2003) Toll-like receptors and activation of autoreactive B cells. Curr Dir Autoimmun 6:105-122.
58. Tao K, et al. (2007) Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 66:905-909. (Pubitemid 46999791)
59. Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525-4528. (Pubitemid 127483768)
60. Nauta AJ, et al. (2002) Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 32:1726-1736. (Pubitemid 34679160)
61. Rosenberg AM, Prokopchuk PA, Lee JS (1988) The binding of native DNA to the collagen-like segment of Clq. J Rheumatol 15:1091-1096.
62. Uwatoko S, Mannik M (1990) The location of binding sites on C1q for DNA. J Immunol 144:3484-3488. (Pubitemid 20146383)
63. lo thymocytes in vivo. Science 250:1720-1723.
64. Kamanaka M, et al. (2006) Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knock-in tiger mouse. Immunity 25:941-952. (Pubitemid 44894945)
65. Adachi O, et al. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150. (Pubitemid 28361303)
66. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB, Jr., Henson PM (1985) Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119:101-110. (Pubitemid 15088729)